West Pharmaceutical Services, Inc. Stock
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
00:00:03 04/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 406.99 USD | -0.22% |
|
+2.18% | +47.92% |
| 11-02 | Jefferies Adjusts West Pharmaceutical Services Price Target to $475 From $410 | MT |
| 10-30 | Stephens Adjusts West Pharmaceutical Services Price Target to $490 From $450 | MT |
| Market Cap | 28.35B 25.33B 23.27B 21.13B 39.68B 2,686B 40.68B 278B 112B 1,417B 106B 104B 4,493B | P/E 2026 * |
47.5x | P/E 2027 * | 39.2x |
|---|---|---|---|---|---|
| Enterprise Value | 27.85B 24.88B 22.86B 20.76B 38.98B 2,638B 39.96B 273B 110B 1,393B 105B 102B 4,414B | EV / Sales 2026 * |
8.14x | EV / Sales 2027 * | 7.6x |
| Free-Float |
92.07% | Yield 2026 * |
0.23% | Yield 2027 * | 0.25% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| WST | Delayed | |
CBOE
| WST | Real-time | |
|
London S.E.
| 0ADY | Delayed | |
|
Tradegate
| WPS | Real-time | |
|
Boerse Muenchen
| WPS | Real-time | |
|
Deutsche Boerse AG
| WPS | Delayed | |
|
Börse Stuttgart
| WPS | Delayed | |
|
Berne S.E.
| WPS | End-of-day quote | |
|
Borsa Italiana
| 1WST | End-of-day quote |
Last Transcript: West Pharmaceutical Services, Inc.
| 1 day | -0.22% | ||
| 1 week | +2.18% | ||
| Current month | -1.36% | ||
| 1 month | +11.51% | ||
| 3 months | +16.97% | ||
| 6 months | +35.36% | ||
| Current year | +47.92% |
| 1 week | 404.52 |  | 438.27 |
| 1 month | 359.49 | | 438.27 |
| Current year | 223.83 | | 438.27 |
| 1 year | 223.83 | | 438.27 |
| 3 years | 187.43 | | 438.27 |
| 5 years | 187.43 | | 475 |
| 10 years | 73.69 | | 475.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michel Lagarde
CEO | Chief Executive Officer | 52 | 31/08/2026 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 04/08/2025 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 01/02/2011 |
Douglas Michels
BRD | Director/Board Member | 69 | 07/03/2011 |
William Feehery
BRD | Director/Board Member | 56 | 12/02/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/30/26 A | Other | Director | 44 | 0.0001% | ||
| 9/15/26 A | Exercice | Head of Human Resources | 7,572 | 0.0108% | ||
| 9/8/26 A | Free | Chief Executive Officer | 51,798 | 0.0736% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.22% | +2.18% | +45.47% | +21.49% | 28.35B | |
| -0.69% | +6.11% | -11.66% | +14.15% | 189B | |
| -0.41% | +5.25% | +9.62% | +36.27% | 121B | |
| +1.22% | +3.03% | -13.29% | +12.43% | 118B | |
| -0.24% | +3.43% | -41.91% | +6.45% | 94.78B | |
| +0.79% | +4.65% | -0.13% | +74.46% | 64.98B | |
| -0.22% | +1.61% | +11.77% | -23.46% | 53.98B | |
| +0.06% | +19.74% | -7.04% | +56.54% | 52.94B | |
| -1.45% | -7.57% | -2.88% | +55.56% | 52.3B | |
| +0.47% | +4.16% | -1.12% | -9.96% | 35.25B | |
| Average | +0.42% | +4.05% | -1.12% | +24.39% | 81.12B | |
| Weighted average by Cap. | +0.56% | +4.31% | -6.45% | +23.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.42B 3.06B 2.81B 2.55B 4.79B 324B 4.91B 33.5B 13.48B 171B 12.84B 12.56B 542B | 3.62B 3.24B 2.97B 2.7B 5.07B 343B 5.2B 35.49B 14.28B 181B 13.6B 13.31B 574B |
| Net income | 666M 595M 547M 497M 932M 63.11B 956M 6.53B 2.63B 33.31B 2.5B 2.45B 106B | 735M 657M 603M 548M 1.03B 69.66B 1.06B 7.2B 2.9B 36.77B 2.76B 2.7B 117B |
| Net Debt | -499M -446M -409M -372M -698M -47.25B -716M -4.89B -1.97B -24.94B -1.87B -1.83B -79.04B | -836M -747M -686M -623M -1.17B -79.16B -1.2B -8.19B -3.29B -41.78B -3.14B -3.07B -132B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/11/26 | $406.99 | -0.22% | 1,075,766 |
| 02/11/26 | $407.88 | -1.15% | 1,457,025 |
| 30/10/26 | $412.62 | -0.97% | 1,062,352 |
| 29/10/26 | $416.67 | +3.23% | 1,873,145 |
| 28/10/26 | $403.64 | +1.34% | 773,291 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WST Stock
Select your edition
All financial news and data tailored to specific country editions
